May 14, 2018 / 11:17 AM / 5 months ago

BRIEF-Unum Therapeutics Posts Q1 Loss Of $0.66 Per Share

May 14 (Reuters) - Unum Therapeutics Inc:

* UNUM THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 LOSS PER SHARE $0.66

* Q1 EARNINGS PER SHARE VIEW $-0.36 — THOMSON REUTERS I/B/E/S

* UNUM THERAPEUTICS - ON TRACK TO FILE IND FOR FIRST SOLID TUMOR PROGRAM, ACTR707 IN COMBINATION WITH TRASTUZUMAB IN 2H 2018

* AS OF MARCH 31, 2018, UNUM HAD CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES OF $32.4 MILLION

* UNUM - PROCEEDS FROM IPO,CONCURRENT PLACEMENT,EXISTING CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES, WILL FUND EXPENSES THROUGH AT LEAST DEC 2019 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below